DCM
TMO icon

Donaldson Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Donaldson Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-443
Closed -$221K – 223
2025
Q1 		$221K Sell
443
-272
-38% -$147K 0.01% 212
2024
Q4 		$372K Sell
715
-6,026
-89% -$3.31M 0.01% 183
2024
Q3 		$4.17M Buy
6,741
+107
+2% +$63.3K 0.16% 66
2024
Q2 		$3.67M Buy
6,634
+352
+6% +$202K 0.15% 69
2024
Q1 		$3.65M Buy
6,282
+561
+10% +$315K 0.15% 73
2023
Q4 		$3.04M Buy
5,721
+531
+10% +$257K 0.14% 76
2023
Q3 		$2.63M Sell
5,190
-286
-5% -$152K 0.12% 78
2023
Q2 		$2.86M Buy
5,476
+59
+1% +$31.8K 0.13% 76
2023
Q1 		$3.12M Buy
5,417
+609
+13% +$343K 0.15% 77
2022
Q4 		$2.65M Sell
4,808
-1,738
-27% -$921K 0.13% 82
2022
Q3 		$3.32M Buy
6,546
+5,417
+480% +$3.03M 0.18% 68
2022
Q2 		$613K Sell
1,129
-14
-1% -$7.71K 0.03% 142
2022
Q1 		$675K Sell
1,143
-112
-9% -$64.3K 0.03% 154
2021
Q4 		$837K Sell
1,255
-11
-0.9% -$6.87K 0.04% 137
2021
Q3 		$723K Buy
1,266
+37
+3% +$20.3K 0.04% 142
2021
Q2 		$620K Sell
1,229
-249
-17% -$117K 0.03% 150
2021
Q1 		$674K Buy
1,478
+50
+4% +$23.9K 0.04% 137
2020
Q4 		$665K Sell
1,428
-494
-26% -$232K 0.04% 128
2020
Q3 		$849K Buy
1,922
+298
+18% +$123K 0.06% 102
2020
Q2 		$589K Buy
1,624
+38
+2% +$12.7K 0.04% 119
2020
Q1 		$450K Buy
1,586
+298
+23% +$94K 0.04% 118
2019
Q4 		$418K Buy
1,288
+259
+25% +$78.5K 0.03% 148
2019
Q3 		$300K Buy
+1,029
New +$295K 0.02% 166

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Donaldson Capital Management's TMO Position: Q2 2025 in Review

Donaldson Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 443 shares — an estimated $221K sold.

Donaldson Capital Management first reported a position in TMO in Q3 2019 and held it in 23 quarters. The position peaked at $4.17M in Q3 2024. 2,454 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Donaldson Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • Donaldson Capital Management sold 443 Thermo Fisher Scientific shares in Q2 2025, an estimated $221K.
  • Donaldson Capital Management first reported a position in Thermo Fisher Scientific in Q3 2019 and held it in 23 quarters.
  • Donaldson Capital Management's Thermo Fisher Scientific position peaked at $4.17M in Q3 2024.
  • 2,454 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Donaldson Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.